Literature DB >> 9643794

Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure.

B Gaston1, S Sears, J Woods, J Hunt, M Ponaman, T McMahon, J S Stamler.   

Abstract

BACKGROUND: Nitric oxide (NO) gas concentrations are high in the expired air of individuals with asthma, but not consistently so in the expired air of people with pneumonia. S-nitrosothiols are naturally occurring bronchodilators, the concentrations of which are raised in the airways of patients with pneumonia. Airway S-nitrosothiols have not been studied in asthma.
METHODS: Tracheal S-nitrosothiol concentrations from eight asthmatic children in respiratory failure were compared with those of 21 children undergoing elective surgery.
RESULTS: Mean S-nitrosothiol concentrations in asthmatic children were lower than in normal children (65 [SD 45] nmol/L vs 502 [SD 429] nmol/L) and did not vary with inspired oxygen concentration or airway thiol concentration.
INTERPRETATION: Severe asthma is associated with low concentrations of airway S-nitrosothiols. This is the first reported deficiency of an endogenous bronchodilator in the human asthmatic airway lining fluid. We suggest that S-nitrosothiol metabolism may be a target for the development of new asthma therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643794     DOI: 10.1016/S0140-6736(97)07485-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  61 in total

1.  Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.

Authors:  Nadzeya V Marozkina; Sean Yemen; Molly Borowitz; Lei Liu; Melissa Plapp; Fei Sun; Rafique Islam; Petra Erdmann-Gilmore; R Reid Townsend; Cheryl F Lichti; Sneha Mantri; Phillip W Clapp; Scott H Randell; Benjamin Gaston; Khalequz Zaman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

Review 2.  Oxidants and asthma.

Authors:  G Caramori; A Papi
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 3.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

4.  GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.

Authors:  Shweta Choudhry; Loretta G Que; Zhonghui Yang; Limin Liu; Celeste Eng; Sung O Kim; Gunjan Kumar; Shannon Thyne; Rocio Chapela; Jose R Rodriguez-Santana; William Rodriguez-Cintron; Pedro C Avila; Jonathan S Stamler; Esteban G Burchard
Journal:  Pharmacogenet Genomics       Date:  2010-06       Impact factor: 2.089

5.  SOD inactivation in asthma: bad or no news?

Authors:  Yvonne Janssen-Heininger; Karina Ckless; Niki Reynaert; Albert van der Vliet
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  S-nitrosothiol repletion by an inhaled gas regulates pulmonary function.

Authors:  M P Moya; A J Gow; T J McMahon; E J Toone; I M Cheifetz; R N Goldberg; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 7.  Proteomic methods for analysis of S-nitrosation.

Authors:  Nicholas J Kettenhofen; Katarzyna A Broniowska; Agnes Keszler; Yanhong Zhang; Neil Hogg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-25       Impact factor: 3.205

8.  Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells.

Authors:  Khalequz Zaman; Marie H Hanigan; Alison Smith; John Vaughan; Timothy Macdonald; David R Jones; John F Hunt; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 9.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

10.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

Authors:  Raed A Dweik; Ronald L Sorkness; Sally Wenzel; Jeffrey Hammel; Douglas Curran-Everett; Suzy A A Comhair; Eugene Bleecker; William Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Elliot Israel; Nizar Jarjour; Wendy Moore; Stephen Peters; Gerald Teague; Benjamin Gaston; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.